Tizanidine Tablet
Product Images NDC 43063-868

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 43063-868). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (43063868)

This is a medication label for Tizanidine tablets 2mg. It provides information about the dosage, storage, and possible side effects of the medication. The tablets may cause drowsiness and caution is advised when driving or performing tasks that require mental alertness. The medication should be kept out of reach of children. The tablets are not interchangeable with capsules of the same medication. The label also includes the lot number, expiration date, and reorder number. The medication is white and has "168" and "BSECT SCRO" markings. The GTIN is 00343063868300 and the SNO is D22B12000001.*

FDA Label Image

Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 01

FDA Label Image

Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 02

FDA Label Image

Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 03

FDA Label Image

Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 04

This text describes the improvement in Ashworth Score during a study, with dosage of 26.8 mg. The time points at which the Ashworth Score was measured are the End of Titration (Study Week 3), End of Maintenance (Study Week 7), and Endpoint (using Last Observation carried forward method).*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.